• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于壳聚糖的前药策略用于高效的细胞内抗癌药物递送。

A prodrug strategy based on chitosan for efficient intracellular anticancer drug delivery.

作者信息

Chen Cheng, Zhou Jiang-Ling, Han Xue, Song Fei, Wang Xiu-Li, Wang Yu-Zhong

机构信息

Center for Degradable and Flame-Retardant Polymeric Materials (ERCPM-MoE), College of Chemistry, State Key Laboratory of Polymer Materials Engineering, National Engineering Laboratory of Eco-Friendly Polymeric Materials (Sichuan), Sichuan University, 29 Wangjiang Road, Chengdu 610064, People's Republic of China.

出版信息

Nanotechnology. 2014 Jun 27;25(25):255101. doi: 10.1088/0957-4484/25/25/255101. Epub 2014 Jun 4.

DOI:10.1088/0957-4484/25/25/255101
PMID:24896540
Abstract

Doxorubicin (DOX), one of the most widely used anticancer drugs, is restricted in clinical application due to its severe side effects and inefficient cellular uptake. To overcome the drawbacks, herein, an endosomal pH-activated prodrug was designed and fabricated by conjugating DOX with chitosan via an acid-cleavable hydrazone bond. The resulting DOX conjugates can self-assemble into nano-sized particles, which were very stable and presented no burst release of DOX at a neutral pH condition. Notably, the nanoparticles exhibited excellent cell uptake properties and a remarkable drug accumulation in tumor cells. Once internalized into the cells, moreover, DOX can be fast released from the nanoparticles, and the release mechanism changed from the anomalous transport at pH 7.4 to the combination pattern of diffusion- and erosion-controlled release at pH 6.0 or 5.0. The prodrugs showed obvious cytotoxicity for HeLa cells with fairly low IC50 values, offering a new platform for targeted cancer therapy.

摘要

阿霉素(DOX)是使用最广泛的抗癌药物之一,由于其严重的副作用和低效的细胞摄取,在临床应用中受到限制。为了克服这些缺点,本文通过酸可裂解的腙键将DOX与壳聚糖共轭,设计并制备了一种内体pH激活前药。所得的DOX共轭物可自组装成纳米级颗粒,这些颗粒非常稳定,在中性pH条件下不会出现DOX的突释。值得注意的是,纳米颗粒表现出优异的细胞摄取特性,并在肿瘤细胞中具有显著的药物积累。此外,一旦内化到细胞中,DOX可以从纳米颗粒中快速释放,释放机制从pH 7.4时的异常转运转变为pH 6.0或5.0时扩散和侵蚀控制释放的组合模式。前药对HeLa细胞显示出明显的细胞毒性,IC50值相当低,为靶向癌症治疗提供了一个新平台。

相似文献

1
A prodrug strategy based on chitosan for efficient intracellular anticancer drug delivery.基于壳聚糖的前药策略用于高效的细胞内抗癌药物递送。
Nanotechnology. 2014 Jun 27;25(25):255101. doi: 10.1088/0957-4484/25/25/255101. Epub 2014 Jun 4.
2
Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.载药介孔硅纳米粒作为载体的靶向抗癌前药。
Nanotechnology. 2011 Nov 11;22(45):455102. doi: 10.1088/0957-4484/22/45/455102. Epub 2011 Oct 21.
3
Disassembly of amphiphilic small molecular prodrug with fluorescence switch induced by pH and folic acid receptors for targeted delivery and controlled release.具有pH和叶酸受体诱导荧光开关的两亲性小分子前药的拆解用于靶向递送和控释
Colloids Surf B Biointerfaces. 2017 Feb 1;150:50-58. doi: 10.1016/j.colsurfb.2016.11.021. Epub 2016 Nov 17.
4
Amphiphilic polycarbonate conjugates of doxorubicin with pH-sensitive hydrazone linker for controlled release.具有 pH 敏感性腙键连接物的阿霉素两亲性聚碳酸酯缀合物用于控制释放。
Colloids Surf B Biointerfaces. 2013 Nov 1;111:542-8. doi: 10.1016/j.colsurfb.2013.06.054. Epub 2013 Jul 10.
5
Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy.乙酰化连接的紫杉醇前药胶束纳米粒作为一种通用且有效的癌症治疗平台。
Biomacromolecules. 2013 Aug 12;14(8):2772-80. doi: 10.1021/bm400615n. Epub 2013 Jul 1.
6
Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.用于靶向递送阿霉素的刺激响应性聚乙二醇化前药
Mater Sci Eng C Mater Biol Appl. 2015 May;50:341-7. doi: 10.1016/j.msec.2015.01.098. Epub 2015 Jan 31.
7
Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.载喜树碱和阿霉素的多功能两亲性前药用于 pH/还原双重响应性药物传递。
ACS Appl Mater Interfaces. 2019 Mar 6;11(9):8740-8748. doi: 10.1021/acsami.8b16363. Epub 2019 Feb 20.
8
Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.用于细胞内酸触发药物递送的天然明胶封端介孔硅纳米粒子。
Langmuir. 2013 Oct 15;29(41):12804-10. doi: 10.1021/la4022646. Epub 2013 Oct 3.
9
A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.一种通过双pH敏感聚电解质复合纳米颗粒进行口服化疗的策略,以实现胃部存活能力、肠道通透性、血液动力学稳定性和细胞内活性。
Eur J Pharm Biopharm. 2015 Nov;97(Pt A):107-17. doi: 10.1016/j.ejpb.2015.10.010. Epub 2015 Oct 26.
10
Rod-like cellulose nanocrystal/cis-aconityl-doxorubicin prodrug: A fluorescence-visible drug delivery system with enhanced cellular uptake and intracellular drug controlled release.棒状纤维素纳米晶/顺式-阿霉素前药:一种具有增强细胞摄取和细胞内药物控制释放的荧光可见药物传递系统。
Mater Sci Eng C Mater Biol Appl. 2018 Oct 1;91:179-189. doi: 10.1016/j.msec.2018.04.099. Epub 2018 May 17.

引用本文的文献

1
How Effective are Key Phytocompound Carrying Polysaccharide Nanocarriers as Anti-Breast Cancer Therapy? A Comprehensive Review of the Literature.携带关键植物化合物的多糖纳米载体作为抗乳腺癌疗法的效果如何?文献综述
Int J Nanomedicine. 2025 Jun 27;20:8393-8413. doi: 10.2147/IJN.S520580. eCollection 2025.
2
Construction of glutathione-responsive paclitaxel prodrug nanoparticles for image-guided targeted delivery and breast cancer therapy.用于图像引导靶向递送和乳腺癌治疗的谷胱甘肽响应型紫杉醇前药纳米颗粒的构建
RSC Adv. 2024 Apr 19;14(18):12796-12806. doi: 10.1039/d4ra00610k. eCollection 2024 Apr 16.
3
Nanoparticulation of Prodrug into Medicines for Cancer Therapy.
前药的药物纳米化用于癌症治疗。
Adv Sci (Weinh). 2021 Sep;8(18):e2101454. doi: 10.1002/advs.202101454. Epub 2021 Jul 29.
4
Engineered EV-Mimetic Nanoparticles as Therapeutic Delivery Vehicles for High-Grade Serous Ovarian Cancer.工程化的类细胞外囊泡纳米颗粒作为高级别浆液性卵巢癌的治疗性递送载体
Cancers (Basel). 2021 Jun 20;13(12):3075. doi: 10.3390/cancers13123075.
5
Morphological and Semi-empirical Study of the Pluronic F68/Imogolite/Sudan III Intersurfaces Composite for the Controlled Temperature Release of Hydrophobic Drugs.用于疏水性药物控温释放的普朗尼克F68/伊莫戈石/苏丹III界面复合材料的形态学和半经验研究
ACS Omega. 2020 Aug 13;5(33):20707-20723. doi: 10.1021/acsomega.9b02965. eCollection 2020 Aug 25.
6
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.采用 CD44 靶向壳聚糖纳米粒将 PLXDC1 小干扰 RNA 选择性递送至内皮细胞用于上皮性卵巢癌的抗血管生成肿瘤治疗。
Drug Deliv. 2018 Nov;25(1):1394-1402. doi: 10.1080/10717544.2018.1480672.
7
Stimuli-responsive chitosan-based nanocarriers for cancer therapy.用于癌症治疗的刺激响应性壳聚糖基纳米载体。
Bioimpacts. 2017;7(4):269-277. doi: 10.15171/bi.2017.32. Epub 2017 Nov 15.
8
Conjugation of Paclitaxel to Hybrid Peptide Carrier and Biological Evaluation in Jurkat and A549 Cancer Cell Lines.紫杉醇与杂合肽载体的偶联及其在Jurkat和A549癌细胞系中的生物学评价。
ACS Med Chem Lett. 2017 Jul 27;8(8):814-819. doi: 10.1021/acsmedchemlett.7b00117. eCollection 2017 Aug 10.
9
Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy.壳聚糖在癌症药物递送与治疗中的多方面应用
Mar Drugs. 2017 Mar 27;15(4):96. doi: 10.3390/md15040096.
10
Programmed Hydrolysis in Designing Paclitaxel Prodrug for Nanocarrier Assembly.用于纳米载体组装的紫杉醇前药设计中的程序化水解
Sci Rep. 2015 Jul 13;5:12023. doi: 10.1038/srep12023.